An Interventional Phase 1b, Randomized, Double-Blind, Sponsor-Open, Placebo-Controlled Study to Investigate the Safety, Tolerability, and Pharmacodynamic Effect of PF-07258669 Compared to Placebo in Older Participants Including Those at Risk of Malnutrition
Latest Information Update: 06 Aug 2025
At a glance
- Drugs PF 07258669 (Primary)
- Indications Malnutrition
- Focus Adverse reactions
- Sponsors Pfizer
Most Recent Events
- 06 Aug 2025 New trial record